コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 Bmax was also inversely related to harsh parenting; boys
2 Bmax was not related to boys' disruptive behavior.
3 Bmax was significantly lower in boys whose parents had h
4 Bmax/Kd (ratio of the distribution volumes in striatum t
5 cantly lower D2 receptor levels (mean = 2.72 Bmax/Kd, SD = 0.3) than subjects who disliked its effect
11 10-lysylbradykinin with a Kd of 0.3 nM and a Bmax of 38 fmol/mg protein ( approximately 40,000 recept
15 und with an affinity (Kd) of 24 microM and a Bmax of 53 x 106 binding sites/cell at 37 degrees C.
16 red with an affinity (Kd) of 37 microM and a Bmax of 65 x 106 binding sites/cell at 37 degrees C.
21 al beta2-AR (4230 receptors per cell) with a Bmax at 129.3 and a KD of 3.19 nM but lack beta1-AR expr
22 specific [3H]bradykinin-binding sites with a Bmax of 271 fmol/mg protein and a Kd of 0.83 nmol/l.
25 IDC, PPH, and NF right ventricles (RV), ACE Bmax was 737+/-78, 638+/-137, and 422+/-49 fmol/mg, resp
26 KD) and maximum binding capacity of analyte (Bmax) values for the interaction of complementary DNA ta
27 KD) and maximum binding capacity of analyte (Bmax) values for the interaction of MoabPf or PoabPf wit
28 002; E2: -20.7%+/-11.7%, P < or = 0.007) and Bmax/Kd (E1: -18.4%+/-8.7%, P < or = 0.002; E2: -13.4%+/
29 of [(3)H]U69,593 to KOR showed that K(d) and Bmax values were not significantly affected by prior in
31 y (Kd, 3 x 10(-7) M versus 5 x 10(-8) M) and Bmax (1.9 x 10(5) versus 7.9 x 10(5)) compared with BAD1
32 InsP3 binding experiments (KD = 23.6 nM and Bmax = 0.46 pmol/mg) suggest the myocytes contain the hi
33 sites for EGF with Kd = 1.78 +/- 0.26 nM and Bmax = 216.8 +/- 19.6 fmol/mg membrane protein were also
34 high affinity site (Kd = 2.3 +/- 0.9 nM and Bmax = 55.5 +/- 8.1 pmol/g tissue) with a pharmacologica
35 inding sites, exhibiting a Kd of 1.44 nM and Bmax of 0.20 mol of [3H]SK&F-107260/mol of alpha v beta
36 ng scans yielded a Kd estimate of 3.4 nM and Bmax of 125-350 nM, in good agreement with the in vitro
38 in plasma membranes with a Kd = 69.6 pM and Bmax = 80 femtomoles/mg protein; no specific binding was
40 in a significant enhancement of the apparent Bmax for muscimol binding without significantly altering
43 l-3-iodoaminophenethyl-1-propylxanthine) are Bmax = 2-5 pmol/mg of protein and K(D) = 0.53 +/- 0.12 n
44 n), and down-regulation of cardiac beta-ARs (Bmax: knockout, 23 +/- 1 fmol/mg protein; WT, 31 +/- 2 f
47 ume (DVstr) and DA D2 receptor availability (Bmax/Kd), for the placebo condition were similar for the
52 Maximum 125I-Ang II (125I-Ang II) binding (Bmax) was increased in LP rats (control n = 9, 291.6 +/-
54 Kd) = 54 pM and maximal theoretical binding (Bmax) = 13 fmol/mg protein), and inhibited by guanosine-
55 ation of konBmax and binding potential (BP = Bmax/Kd) and the reproducibility of the measures assesse
56 ysis [LEGA]), using binding potential (BPF = Bmax/Kd) (Bmax = maximum number of binding sites; Kd = d
57 to estimate 5-HT1A binding potential (BPF = Bmax/KD, where Bmax = available receptors and KD = disso
58 ding affinity for noncrosslinked fibrin, but Bmax was increased in the presence of ultrasound, from 3
60 02 nmol/L), with a maximum binding capacity (Bmax) of 414 fmol/10(6) cells (2.5 x 10(5) GRP-R/cell).
62 l protein, with the ligand-binding capacity (Bmax) typically 20-fold higher than that obtained with r
65 gh affinity (Kd=5.2nM) and limited capacity (Bmax of 14.2fmol/mg of protein), confirming the presence
68 urable using SK-N-MC neuroepithelioma cells (Bmax, 4.28 x 10(7) molecules of chelator/cell; and Kd, 2
72 f a high level of CB1 receptors in controls (Bmax=12.0+/-0.3 pmol mg-1 protein) which decreased signi
74 glycine binding sites increased at 45 days (Bmax:392 +/- 30 vs. 561 +/- 96 fmol/mg protein, P < 0.00
75 rotein, P < 0.005) but decreased at 60 days (Bmax:583 +/- 85 vs. 411 +/- 65 fmol/mg protein, P < 0.00
77 found to be 15.3 pM (KD) and 81.02m degrees (Bmax) with probe 1 and 54.9pM and 55.29m degrees (Bmax),
81 ed to measure the affinity (Kd) and density (Bmax) of kainate and AMPA receptors in striatum, cortex
83 ith DPDPE for 2 or 4 days decreased density (Bmax) of [3H]DPDPE to bind to brain homogenates by 77 an
84 bably the result of a loss of nAChR density (Bmax ) and changes in the subunit composition of nAChRs.
85 is due to a change in the receptor density (Bmax) and/or affinity (measured as Kd) of the mu (mu) an
92 measures obtained were V3 (receptor density [Bmax]/equilibrium dissociation constant [KD]), V3' (f1 x
96 cDNAs resulted in high levels of expression (Bmax = 95 +/- 6 pmol/mg) of the C-His-TxA2 receptors.
99 iazepine receptor concentration ([(11) C]FMZ Bmax) revealed significant intergroup differences in the
102 another lower affinity KD and another higher Bmax, but for ReLPS, LBP increased the affinity of bindi
103 In antidepressant-treated suicides however, Bmax values were lower in all regions, reaching statisti
104 MP-induced changes in striatal DV and in Bmax/Kd, as well as the behavioral and cardiovascular ef
106 eric agonists detects significant changes in Bmax values with little change in Kd, suggesting a G pro
110 In the frontal cortex, the reduction in Bmax values was significantly greater in 3 months vs. 22
114 an up-regulation of mu-receptors (increased Bmax) in the striatum of rats treated with 0.3 mg/kg nic
116 e number of glycine binding sites increased (Bmax:392 +/- 30 vs. 583 +/- 30 fmol/mg protein at 45 and
117 ]), using binding potential (BPF = Bmax/Kd) (Bmax = maximum number of binding sites; Kd = dissociatio
119 nogen (HK) (apparent Kd of 23 +/- 11 nmol/L, Bmax of 1.7 +/- 0.5 x 10(7) sites per cell [mean +/- SD,
120 scovery process, involving expression level (Bmax) and biodistribution determination, a PET-specific
123 more numerous in the cocaine users: the mean Bmax value was 9.0 fmol bound/microg protein (SD = 2.8)
124 antly reduced in chronic EtOH exposed mouse (Bmax = 7.58 +/- 0.22 for control; 6.42 +/- 0.20 pmol/mg
125 ceptor exhibited high (Kd = 0.4 +/- 0.08 nM, Bmax = 0.7 +/- 0.2 pmol/mg protein; n = 4) and low (Kd =
129 sic curve with high affinity (K(d) = 1.4 nM, Bmax = 3157 sites) and low affinity (K(d) = 157 nM, Bmax
130 rotein; n = 4) and low (Kd = 75 +/- 27.4 nM, Bmax = 7.1 +/- 3.6 pmol/mg protein; n = 4) affinity for
133 ed platelets (Kd app of approximately 10 nm; Bmax of approximately 1,500 sites/platelet) utilizing re
142 ble and of high affinity (KD = 74 +/- 14 PM, Bmax = 679 +/- 88 fmol/mg protein; three experiments).
145 , kinetic analysis of the binding potential [Bmax/(Kd x Vd)] using the assumption of equal partition
146 d alpha1B-adrenoceptor density ([3H]prazosin Bmax) versus control groups by 12% (1 microM AO) and 72%
147 There was an up-regulation of mu-receptor (Bmax increased) in the spinal cord of morphine tolerant
148 induced decrease in the number of receptors (Bmax) and receptor binding affinity (Kd) during hypoxia.
156 0 to 5.5 nM, and the number of binding sites Bmax ranged from 630 to 1360 molecules of C1q per bacter
158 platelet tritiated paroxetine binding sites (Bmax) and dissociation constant (Kd) values were measure
160 constant (Kd) and the maximum binding sites (Bmax) in a bovine membrane preparation and similar rabbi
161 he maximum number of receptor binding sites (Bmax) values were derived from baseline VT and from the
164 ficity, and maximum number of binding sites (Bmax) were quantified, with adenoviral-expressed CXCR4 o
166 creased the number of 5-HT1A receptor sites (Bmax = 108 +/- 8.20 fmol/mg protein and 152.31 +/- 13.36
168 aturable (maximal density of receptor sites, Bmax = 1.56 pmol (mg protein)-1) binding site that exhib
170 /Bs greater than 1.2, and the maximum T/B (T/Bmax) was determined by the voxel with the greatest T/B
181 ing revealed that hypoxia decreased both the Bmax and the Kd of the NMDA receptor for [3H]glutamate a
182 analyses showed that HTG-VLDL decreased the Bmax for 125I-labeled Glu-Pmg ligand binding approximate
185 h an IC50 value of 0.5 microM, decreased the Bmax value of the binding sites with a slight increase i
187 d that there was no alteration in either the Bmax or Kd for this ligand, suggesting that the changes
190 TH was also found to cause a decrease in the Bmax for [3H]raclopride binding, suggesting that persist
193 hr resulted in a significant decrease in the Bmax value of opioid receptors, with a maximum reduction
197 necessity of estrogen priming, increased the Bmax of baclofen binding to GABAB receptors in the neoco
199 ith (+)-pentazocine or PRE-084 increased the Bmax values of [(3)H]WIN35428 binding to DAT in rat stri
202 Q mutation in Na,K-ATPase alpha3 reduced the Bmax for ouabain binding and the ATPase activity of alph
203 , or 3.0 microM FSCPX for 30 min reduced the Bmax of [3H]CPX binding by 41 +/- 10%, 67 +/- 6%, and 80
204 S]GTP gamma S binding in SPM showed that the Bmax of cannabinoid stimulated binding was significantly
205 - 71 fmol/mg, which correlated well with the Bmax value determined using [3H]spiperone (227 +/- 83 fm
207 ing potential (BP) (which is proportional to Bmax/KD, in which Bmax is transporter density and KD is
209 HT1A binding potential (BPF = Bmax/KD, where Bmax = available receptors and KD = dissociation constan
210 strained to be constant across ROIs, whereas Bmax was allowed to be ROI-dependent and animal-dependen
211 (which is proportional to Bmax/KD, in which Bmax is transporter density and KD is dissociation const
212 icular membranes from the hearts of both WT (Bmax = 52 fmol/mg protein) and beta3 KO (Bmax = 53 fmol/
213 brium dissociation constant [KD]), V3' (f1 x Bmax/KD), and RT (specific-to-nondisplaceable tissue rat
214 on analysis of [3H]ryanodine binding yielded Bmax = 150 fmol/mg of protein and Kd = 110 nM in DAKIKI
215 ioligand 125I-labeled AB-MECA, which yielded Bmax and Kd values of 1.31 pmol/mg protein and 3.19 nmol
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。